Literature DB >> 10920828

[Superselective fibrinolysis for a middle cerebral artery embolism caused by a left atrial myxoma: case report].

T Yamanome1, K Yoshida, K Miura, A Ogawa.   

Abstract

A case of successful treatment by local fibrinolysis of a middle cerebral artery embolism caused by a thrombus from a left atrial myxoma is reported. A 62-year-old woman using a pacemaker and suffering from sick sinus syndrome was admitted on December 29th 1996, complaining of transient restlessness. CT and cerebral angiography revealed no abnormal vascular lesions. Eighteen months after the initial episode, she suffered a sudden onset of left hemiparesis and loss of consciousness. CT scan performed during the second episode revealed no lesions and, in particular, no early CT infarction sign, but emergent cerebral angiography revealed a right middle cerebral artery embolic occlusion. Local fibrinolysis using a tissue plasminogen activator was performed within 3 hours after the beginning of the episode, and partial recanalization was obtained within one hour after initiation of the fibrinolytic therapy. On the first hospital day, though CT revealed a small low-density area in the right basal ganglia, motor deficits gradually improved. Considering the possibility of a cardiac source of the embolism, trans-esophageal echocardiography was performed and revealed a left atrial tumor suspected to be a myxoma. It was removed by surgery on the 34th hospital day. Histological examination proved it to be a myxoma. Nine months after local fibrinolytic therapy, the patient returned to work. The diagnosis of cerebral embolism caused by cardiac myxoma is difficult to make at the time when the patient is first examined after admission. It is also hard to discover during emergent cerebral angiography with fibrinolytic therapy. Therefore, in the case of patients with cerebral embolism for which local fibrinolysis is ineffective, it should be presumed that cardiac myxoma is the source of the embolus. Direct PTA alone may be effective for such tumoral embolism.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10920828

Source DB:  PubMed          Journal:  No Shinkei Geka        ISSN: 0301-2603


  7 in total

1.  Biatrial myxoma and cerebral ischemia successfully treated with intravenous thrombolytic therapy and surgical resection.

Authors:  Morhaf Ibrahim; Cezar Iliescu; Hazim J Safi; Maximilian L Buja; David D McPherson; Francisco Fuentes
Journal:  Tex Heart Inst J       Date:  2008

2.  Intra-arterial treatment in a child with embolic stroke due to atrial myxoma.

Authors:  Ido van den Wijngaard; Marieke Wermer; Marianne van Walderveen; Natalie Wiendels; Cacha Peeters-Scholte; Geert Lycklama À Nijeholt
Journal:  Interv Neuroradiol       Date:  2014-06-17       Impact factor: 1.610

3.  Cerebral embolism associated with left atrial myxoma that was treated with thrombolytic therapy.

Authors:  Naoto Kohno; Yuko Kawakami; Chizuko Hamada; Genya Toyoda; Hirokazu Bokura; Shuhei Yamaguchi
Journal:  Case Rep Neurol       Date:  2012-01-25

4.  Intravenous Thrombolysis for Embolic Stroke due to Cardiac Myxoma.

Authors:  Mu-Chien Sun; Hui-Chun Tai; Chien-Hui Lee
Journal:  Case Rep Neurol       Date:  2011-01-20

5.  Intravenous thrombolysis in a patient with left atrial myxoma with acute ischemic stroke.

Authors:  Girish Baburao Kulkarni; Ravi Yadav; Veerendrakumar Mustare; Sailesh Modi
Journal:  Ann Indian Acad Neurol       Date:  2014-10       Impact factor: 1.383

6.  Mechanical Endovascular Recanalization in a Patient with Middle Cerebral Artery Occlusion by Tumorous Emboli Originating from Cardiac Myxoma.

Authors:  Bikei Ryu; Tatsuya Ishikawa; Shinsuke Sato; Akiyoshi Yokote; Hidetoshi Nakamoto; Masaki Nie; Yoshikazu Okada
Journal:  NMC Case Rep J       Date:  2015-03-23

7.  Cardiac Myxoma and Cerebrovascular Events: A Retrospective Cohort Study.

Authors:  Maria-Ioanna Stefanou; Dominik Rath; Vera Stadler; Hardy Richter; Florian Hennersdorf; Henning F Lausberg; Mario Lescan; Simon Greulich; Sven Poli; Meinrad P Gawaz; Ulf Ziemann; Annerose M Mengel
Journal:  Front Neurol       Date:  2018-10-03       Impact factor: 4.003

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.